Assen Dudov
- Pulmonary and Respiratory Medicine top 10%
- Oncology
- Molecular Biology
- Surgery
- Neurology top 10%
- Co-authors
- U. MengsI. BazinMartin SchülerIgor BondarenkoBohuslav MelicharFlorian LordickIhor VynnychenkoAndriy Rusyn
- Topics
- Gastric Cancer Management and Outcomes (6 papers)Barrier Structure and Function Studies (4 papers)Cancer Treatment and Pharmacology (4 papers)
- Cited by
- NeurologyGastroenterologyOncology
In The Last Decade
Assen Dudov
16 papers receiving 510 citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Pulmonary and Respiratory Medicine 217
- Oncology 208
- Molecular Biology 129
- Surgery 111
- Neurology 108
Countries citing papers authored by Assen Dudov
This map shows the geographic impact of Assen Dudov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assen Dudov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assen Dudov more than expected).
Fields of papers citing papers by Assen Dudov
This network shows the impact of papers produced by Assen Dudov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assen Dudov. The network helps show where Assen Dudov may publish in the future.
Co-authorship network of co-authors of Assen Dudov
This figure shows the co-authorship network connecting the top 25 collaborators of Assen Dudov. A scholar is included among the top collaborators of Assen Dudov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Assen Dudov. Assen Dudov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinomabreakdown → | 244 |
| 2 | 16 | |
| 3 | 7 | |
| 4 | 18 | |
| 5 | 2 | |
| 6 | 35 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 30 | |
| 10 | 2 | |
| 11 | Current diagnostic approaches in tumor-induced bone disease. | 9 |
| 12 | Nuclear medicine approaches in the monitoring of thyroid cancer patients. | 4 |
| 13 | Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial. | 78 |
| 14 | The standardised mistletoe extract PS76A2 improves QoL in patients with breast cancer receiving adjuvant CMF chemotherapy: a randomised, placebo-controlled, double-blind, multicentre clinical trial. | 59 |
| 15 | 5 | |
| 16 | 3 |
About Assen Dudov
Assen Dudov is a scholar working on Neurology, Gastroenterology and Oncology, having authored 16 papers that have together received 522 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (6 papers), Barrier Structure and Function Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Neurology (108 citations), Gastroenterology (62 citations) and Oncology (208 citations). Assen Dudov has collaborated with scholars based in Russia, Bulgaria and Ukraine. Frequent co-authors include U. Mengs, I. Bazin, Martin Schüler, Igor Bondarenko, Bohuslav Melichar, Florian Lordick, Ihor Vynnychenko, Andriy Rusyn, Uğur Şahin and Christoph Huber. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.